Admin: IPR And Access To Medicines In India
CHANAKYA NATIONAL LAW UNIVERSITY, PATNA
Economics-II
Project on:-
IPR and access to medicines in india
Submitted To: Mrs. Shivani Mohan (Faculty for Economics)
Submitted By: Somya Priyadarshini Roll No.: 471 Semester: IVth , 2nd Year.
ACKNOWLEDGEMENT
The present project on the âIPR and access to medicines in Indiaâ has been able to get its final shape with the support and help of people from various quarters. My sincere thanks go to all the members without whom the study could not have come to its present state. I am proud to acknowledge gratitude to the individuals during my study and without whom the study may not be completed. I have taken this opportunity to thank those who genuinely helped me.
With immense pleasure, I express my deepest sense of gratitude to Mrs.Shivani Mohan, Faculty for Economics, Chanakya National Law University for helping me in my project. I am also thankful to the whole Chanakya National Law University family that provided me all the material I required for the project. Not to forget thanking to my parents without the co-operation of which completion of this project would not had been possible.
I have made every effort to acknowledge credits, but I apologies in advance for any omission that may have inadvertently taken place.
Last but not least I would like to thank Almighty whose blessing helped me to complete the project.
RESEARCH METHODOLOGY
Method of Research:
The researcher has adopted a purely doctrinal method of research. The researcher has made use of the library at the Chanakya National Law University and also the internet sources.
Aims and Objectives:
The aim of the project is to present an overview of the terms âIPR and access to medicines in Indiaâ through different
Economics-II
Project on:-
IPR and access to medicines in india
Submitted To: Mrs. Shivani Mohan (Faculty for Economics)
Submitted By: Somya Priyadarshini Roll No.: 471 Semester: IVth , 2nd Year.
ACKNOWLEDGEMENT
The present project on the âIPR and access to medicines in Indiaâ has been able to get its final shape with the support and help of people from various quarters. My sincere thanks go to all the members without whom the study could not have come to its present state. I am proud to acknowledge gratitude to the individuals during my study and without whom the study may not be completed. I have taken this opportunity to thank those who genuinely helped me.
With immense pleasure, I express my deepest sense of gratitude to Mrs.Shivani Mohan, Faculty for Economics, Chanakya National Law University for helping me in my project. I am also thankful to the whole Chanakya National Law University family that provided me all the material I required for the project. Not to forget thanking to my parents without the co-operation of which completion of this project would not had been possible.
I have made every effort to acknowledge credits, but I apologies in advance for any omission that may have inadvertently taken place.
Last but not least I would like to thank Almighty whose blessing helped me to complete the project.
RESEARCH METHODOLOGY
Method of Research:
The researcher has adopted a purely doctrinal method of research. The researcher has made use of the library at the Chanakya National Law University and also the internet sources.
Aims and Objectives:
The aim of the project is to present an overview of the terms âIPR and access to medicines in Indiaâ through different
Bibliography: [6] See: Correa C. (2006) Implications of bilateral free trade agreements on access to medicines. Bulletin World Health Organization 2006, 84(5):399-404. [7] Correa C. (2009). Negotiation of a free trade Agreement European Union-India: Will India accept TRIPS-plus protection? Oxfam Germany and the Church Development Service. [8] Daniele D., Daniela M. Impending Flop for Brand Antiretrovirals in the Emerging Markets? Open AIDS J. 2008; 2: 68–71. [10] Satyanarayana K., Srivastava S. Patent Pooling for Promoting Access to Antiretroviral Drugs (ARVs) - A Strategic Option for India. Open AIDS J. (2010)4:41-53. [12] Oxfam (2011) Briefing Paper. Eye on the Ball Medicine regulation – not IP enforcement – can best deliver quality medicines. [13]Waning B, Kyle M, Diedrichsen E, et al (2010) Intervening in global markets to improve access to HIV/AIDS treatment: an analysis of international policies and the dynamics of global antiretroviral medicines markets. Glob & Health 6(9).